Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2009-12-21
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Colony-stimulating factors such as G-CSF may increase the number of
immune cells found in bone marrow or peripheral blood and may help a person 's immune system
recover from the side effects of chemotherapy.
PURPOSE: Phase I/II trial to study the effectiveness of docetaxel and epirubicin with and
without G-CSF in treating women with metastatic breast cancer.